Summary
AbbVie Inc. (ABBV) has filed a Form 8-K on April 25, 2025, to report its financial results for the first quarter ended March 31, 2025. The primary purpose of this filing is to furnish a press release containing these key financial performance details. Investors should refer to the press release (Exhibit 99.1) for comprehensive information regarding AbbVie's operational and financial condition during the first quarter of 2025, as this 8-K primarily serves as a notification and vehicle for distributing that information.
Key Highlights
- 1AbbVie Inc. announced its first-quarter 2025 financial results on April 25, 2025.
- 2The filing is an 8-K Current Report, primarily containing a press release with financial results.
- 3Investors should consult the furnished press release (Exhibit 99.1) for detailed financial and operational information.
- 4The event date associated with the reported results is April 24, 2025.
- 5The filing includes standard exhibits, such as the press release and an Inline XBRL cover page.